WO2025224715 - METHODS FOR IMPROVING PRECISE GENOME MODIFICATION AND REDUCING UNWANTED MUTATIONS BY CRISPR-CAS EDITING

National phase entry is expected:
Publication Number WO/2025/224715
Publication Date 30.10.2025
International Application No. PCT/IB2025/054391
International Filing Date 28.04.2025
Title **
[English] METHODS FOR IMPROVING PRECISE GENOME MODIFICATION AND REDUCING UNWANTED MUTATIONS BY CRISPR-CAS EDITING
[French] PROCÉDÉS D'AMÉLIORATION DE MODIFICATION PRÉCISE DU GÉNOME ET DE RÉDUCTION DE MUTATIONS INDÉSIRABLES PAR ÉDITION DE CRISPR-CAS
Applicants **
KING ABDULLAH UNIVERISTY OF SCIENCE AND TECHNOLOGY
Inventors
LI, Mo
YUAN, Baolei
Priority Data
63/639,573   26.04.2024   US
63/723,422   21.11.2024   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2662
EPO Filing, Examination, Granting11975
Japan Filing, Examination, Granting2285
South Korea Filing, Examination, Granting2336
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 23,998
Contact Us
Abstract[English] Compositions and methods for increasing the homology directed repair (HDR) efficiency following CRISPER/CAS mediated gene editing are disclosed, include (A) Agents that reduce PoLQ level/activity in a cell; (B) agents that increase RPA levels/activity in a cell and (C) fluorophore-modified nucleic acids used in gene editing.[French] Des compositions et des procédés pour augmenter l'efficacité de réparation dirigée par l'homologie (HDR) après l'édition génique médiée par CRISPER/CAS sont divulgués, comprenant (A) des agents qui réduisent le niveau/l'activité de PoLQ dans une cellule ; (B) des agents qui augmentent les niveaux/l'activité de RPA dans une cellule et (C) des acides nucléiques modifiés par fluorophore utilisés dans l'édition génique.

Rejoining the server...